About DRI Biosciences
DRI Biosciences is a company based in Frederick (United States) founded in 2014 by Hao Chen.. DRI Biosciences offers products and services including Aging Reversal Technology. DRI Biosciences operates in a competitive market with competitors including Nura Bio, Healx, Cingulate, STALICLA and PaxMedica, among others.
- Headquarter Frederick, United States
- Founders Hao Chen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dri Biosciences Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$532.43 K (USD), Grant
Sep 15, 2019
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DRI Biosciences
DRI Biosciences offers a comprehensive portfolio of products and services, including Aging Reversal Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Breakthrough solution for reversing aging and treating disorders.
Funding Insights of DRI Biosciences
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $532,431
-
First Round
First Round
(01 Feb 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Grant - DRI Biosciences | Valuation |
investors |
|
| Feb, 2016 | Amount | Grant - DRI Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DRI Biosciences
DRI Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DRI Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DRI Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dri Biosciences Comparisons
Competitors of DRI Biosciences
DRI Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nura Bio, Healx, Cingulate, STALICLA and PaxMedica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic solutions and neuroprotective medicines for neurological disorders are provided.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for rare diseases is developed.
|
|
| domain | founded_year | HQ Location |
Cingulate is focused on developing treatments for ADHD and anxiety.
|
|
| domain | founded_year | HQ Location |
Precision medicines for neurodevelopmental disorders are manufactured using DEPI technology.
|
|
| domain | founded_year | HQ Location |
Drugs for neurodevelopmental disorders are developed by PaxMedica.
|
|
| domain | founded_year | HQ Location |
Drugs are developed to treat multiple neurological disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about DRI Biosciences
When was DRI Biosciences founded?
DRI Biosciences was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is DRI Biosciences located?
DRI Biosciences is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.
Who is the current CEO of DRI Biosciences?
Hao Chen is the current CEO of DRI Biosciences. They have also founded this company.
What does DRI Biosciences do?
DRI Biosciences was founded in 2014 and is based in Frederick, United States. Operations focus on preclinical discovery of treatments for neurodevelopmental disorders, including autism spectrum disorders and Fragile X syndrome. The lead candidate, ACT01, is under development in animal models for Fragile X syndrome. Proprietary biomarkers for Fragile X syndrome are also being advanced as companion diagnostics within the biopharmaceutical sector.
Who are the top competitors of DRI Biosciences?
What products or services does DRI Biosciences offer?
DRI Biosciences offers Aging Reversal Technology.
Who are DRI Biosciences's investors?
DRI Biosciences has 1 investor. Key investors include HHS.